The wide phenotypic spectrum of thiamine metabolism dysfunction syndrome 5 and its treatment
Open Access
- 4 April 2025
- journal article
- review article
- Published by Springer Nature in Orphanet Journal of Rare Diseases
- Vol. 20 (1) , 1-9
Abstract
Thiamine metabolism dysfunction syndrome 5 (TMDS5) is a rare inborn error of metabolism caused by variants in TPK1, leading to reduced TPK levels. This enzyme is crucial for the production of thiamine pyrophosphate, the active form of thiamine, a vital coenzyme in numerous metabolic pathways. The clinical presentation exhibits a diverse range of manifestations. In this review, we explore reported cases in the literature and present two cases representing the extremes of the clinical spectrum: recurrent ataxia and Leigh syndrome. The former phenotype follows a milder course. The second one is characterized by early onset and severe symptoms, including dystonia, epilepsy, and developmental regression, progressing rapidly to severe disability with high mortality. Typically, children exposed to infectious or traumatic triggers display episodes marked by ataxia and dystonia, with periods of good health or only mild disabilities in between. Treatment with the phosphorylated thiamine active bioform, TPP, is more effective in the recurrent ataxia form, especially when initiated promptly at symptom onset. Further studies are needed to identify available biomarkers and establish correlations between different variants, severity, and treatment response.Keywords
This publication has 19 references indexed in Scilit:
- Thiamine metabolism dysfunction syndrome 5 (THMD5) mimicking acute disseminated encephalomyelitisAmerican Journal of Medical Genetics Part A, 2023
- Movement disorders associated with thiamine pyrophosphokinase deficiency: Intrafamilial variability in the phenotypeClinical Neurology and Neurosurgery, 2020
- Thiamine phosphokinase deficiency and mutation in TPK1 presenting as biotin responsive basal ganglia diseaseClinica Chimica Acta, 2019
- Genetic defects of thiamine transport and metabolism: A review of clinical phenotypes, genetics, and functional studiesJournal of Inherited Metabolic Disease, 2019
- Reduced thiamine binding is a novel mechanism for TPK deficiency disorderMolecular Genetics and Genomics, 2018
- TPK1 mutation induced childhood onset idiopathic generalized dystonia: Report of a rare mutation and effect of deep brain stimulationJournal of the Neurological Sciences, 2017
- Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular PathologyGenetics in Medicine, 2015
- Expanding the clinical and molecular spectrum of thiamine pyrophosphokinase deficiency: A treatable neurological disorder caused by TPK1 mutationsMolecular Genetics and Metabolism, 2014
- Thiamine pyrophosphokinase deficiency causes a Leigh Disease like phenotype in a sibling pair: identification through whole exome sequencing and management strategiesMolecular Genetics and Metabolism Reports, 2014
- Thiamine Pyrophosphokinase Deficiency in Encephalopathic Children with Defects in the Pyruvate Oxidation PathwayThe American Journal of Human Genetics, 2011